In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents

Mohammad Reza Hajizadeh , Haniyeh Maleki, Mahmood Barani, Mohammad Ali Fahmidehkar, Mehdi Mahmoodi, Masoud Torkzadeh-Mahani

Abstract


The low solubility of the plant-extracted agent like D-limonene in cancer therapy is a critical problem. In this study, we prepared D-limonene-loaded niosomes (D-limonene/Nio) for cancer therapy through in vitro cytotoxicity assay of HepG2, MCF-7, and A549 cell lines. The niosomal formulation was prepared by film hydration technique with Span® 40: Tween® 40: cholesterol (35:35:30 molar ratio) and characterized for vesicle distribution size, morphology, entrapment efficiency (EE%), and in vitro release behaviour.  The obtained niosomes showed a nanometric size and spherical morphology with EE% about 87 ± 1.8%. Remarkably prolonged release of D-limonene from niosomes compared to free D-limonene observed. The loaded formulation showed significantly enhanced cytotoxic activity with all three cancer cell lines (HepG2, Macf-7 and A549) at the concentration of 20 µM. These results indicated that niosome loaded with phytochemicals can be a promising nano-carrier for cancer therapy applications.

Keywords


Cancer therapy; D-limonene; Niosome; Solubility.

Full Text:

PDF

References


Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381-387.

Thun M, Linet MS, Cerhan JR, Haiman ChA, Schottenfeld D, editors. Cancer epidemiology and prevention. 3rd edition. United Kingdom: Oxford University Press; 2006. pp. 763-786.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.

Mugada V, Ramineni H, Padala D. 5-Fluorouracil induced severe febrile neutropenia and death. J Young Pharm. 2017;9(1):133-134.

Li WJ, Lian YW, Guan QS, Li N, Liang WJ, Liu WX, et al. Liver-targeted delivery of liposome‑encapsulated curcumol using galactosylated‑stearate. Exp Ther Med. 2018;16(2):925-930.

Lazutka JR, Mierauskiene J, Slapsyte G, Dedonyte V. Genotoxicity of dill (Anethum graveolens L.), peppermint (Mentha piperita L.) and pine (Pinus sylvestris L.) essential oils in human lymphocytes and Drosophila melanogaster. Food Chem Toxicol. 2001;39(5):485-492.

Rattanamaneerusmee A, Thirapanmethee K, Nakamura Y, Bongcheewin B, Chomnawang MT. Chemopreventive and biological activities of Helicteres isora L. fruit extracts. Res Pharm Sci. 2018,13(1):484-492.

Eghbali-Feriz S, Taleghani A, Al-Najjar H, Emami SA, Rahimi H, Asili J, et al. Anti-melanogenesis and anti-tyrosinase properties of Pistacia atlantica subsp. mutica extracts on B16F10 murine melanoma cells. Res Pharm Sci. 2018;13(1):533-545.

Liu R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003; 78(3 Suppl):517S-520S.

Nili-Ahmadabadi A, Alibolandi P, Ranjbar A, Mousavi L, Nili-Ahmadabadi H, Larki-Harchegani A, et al. Thymoquinone attenuates hepatotoxicity and oxidative damage caused by diazinon: an in vivo study. Res Pharm Sci. 2018;13(1):500-508.

Sun J. D-Limonene: safety and clinical applications. Altern Med Rev. 2007;12(3):259-264.

Jing L, Zhang Y, Fan S, Gu M, Guan Y, Lu X, et al. Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity. Eur J Pharmacol. 2013;715(1-3):46-55.

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, et al. D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer. OncoTargets Ther. 2018;11:1833-1847.

Lu XG, Feng BA, Zhan LB, Yu ZH. D-limonene induces apoptosis of gastric cancer cells. Zhonghua Zhong Liu Za Zhi. 2003;25(4):325-327.

Guyton KZ, Kensler TW. Prevention of liver cancer. Curr Oncol Rep. 2002;4(1):464-470.

Murali R, Karthikeyan A, Saravanan R. Protective effects of D-limonene on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rats. Basic Clin Pharmacol Toxicol. 2013;112(3):175-181.

Perchyonok VT, Souza J, Zhang Sh, Moodley D, Grobler S. Bio-active designer materials and dentures: from design to application. Int J Med Nano Res. 2015;2(1):2-12.

Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol. 2008;26(1):74-85.

Khajeh Ebrahimi A, Barani M, Sheikhshoaie I. Fabrication of a new superparamagnetic metal-organic framework with core-shell nanocomposite structures: Characterization, biocompatibility, and drug release study. Mater Sci Eng C, 2018;92:349-355.

Uchegbu, IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1-2):33-70.

Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16-20.

Barani M, Mirzaei M, Torkzadeh-Mahani M, Nematollahi MH. Lawsone-loaded niosome and its antitumor activity in MCF-7 breast cancer cell line: a Nano-herbal treatment for Cancer. DARU J Pharm Sci. 2018;26(1):11-17.

Davarpanah F, Khalili Yazdi A, Barani M, Mirzaei M, Torkzadeh-Mahani M. Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes. DARU J Pharm Sci. 2018. DOI: 10.1007/s40199-018-0215-3.

Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22-36.

Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114(2):242-250.

Stockwell AF, Davis SS, Walker SE. In vitro evaluation of alginate gel systemsas sustained release drug delivery systems. J Control Release. 1986;3(1-4):167-175.

Rahdar A, Taboada P, Hajinezhad MR, Barani M, Beyzaei H. Effect of tocopherol on the properties of Pluronic F127 microemulsions: Physico-chemical characterization and in vivo toxicity. J Mol Liq. 2019;277:624-630.

Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011;34(2):945-953.

Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32(5):1119-1123.

Hans ML. Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid St M. 2002;6(4):319-327.

Vandresen F, Falzirolli H, Almeida Batista SA, da Silva-Giardini AP, de Oliveira DN, Catharino RR, et al. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines. Eur J Med Chem. 2014;79:110-116.

Hemati M, Haghiralsadat F, Yazdian F, Jafari F, Moradi A, Malekpour-Dehkordi Z. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artif Cells Nanomed Biotechnol. 2018:47(1):1295-1311.

Khan M, Ang CY, Wiradharma N, Yong LK, Liu S, Liu L, et al. Diaminododecane-based cationic bolaamphiphile as a non-viral gene delivery carrier. Biomaterials. 2012;33(18):4673-4680.

Sarwa KK, Suresh PK, Debnath M, Ahmad MZ. Tamoxifen citrate loaded ethosomes for transdermal drug delivery system: preparation and characterization. Curr Drug Deliv. 2013;10(4):466-476.

Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. ‎Pharm Res. 2006;23(1):184-195.

Thakkar M, Brijesh S. Brijesh, Physicochemical investigation and in vivo activity of anti-malarial drugs co-loaded in Tween 80 niosomes. J Liposome Res. 2017:28(4):315-321.

Attia IA, El-Gizawy SA, Fouda MA, Donia AM. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech. 2007;8(4):206-212.

Abbasi S, Kajimoto K, Harashima H. Critical parameters dictating efficiency of membrane-mediated drug transfer using nanoparticles. Int J Pharm. 2018;553(1-2):398-407.

Kanaani L. Effects of cisplatin-loaded niosomal nanoparticleson BT-20 human breast carcinoma cells. Asian Pac J Cancer Prev. 2017;18(2):365-368.

Behroozeh A, Tabrizi MM, Kazemi SM, Choupani E, Kabiri N, Ilbeigi D, et al.Evaluation the anti-cancer effect of pegylated nano-niosomal gingerol, on breast cancer cell lines (T47D), in-vitro. Asian Pac J Cancer Prev. 2018;19(3):645-648.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.